Page last updated: 2024-11-04

sulfasalazine and Cleft Lip

sulfasalazine has been researched along with Cleft Lip in 3 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Cleft Lip: Congenital defect in the upper lip where the maxillary prominence fails to merge with the merged medial nasal prominences. It is thought to be caused by faulty migration of the mesoderm in the head region.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Källén, B1
Craxi, A1
Pagliarello, F1
Amitai, Y1
Leventhal, A1

Other Studies

3 other studies available for sulfasalazine and Cleft Lip

ArticleYear
Maternal drug use and infant cleft lip/palate with special reference to corticoids.
    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 2003, Volume: 40, Issue:6

    Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Cleft Lip; Cl

2003
Possible embryotoxicity of sulfasalazine.
    Archives of internal medicine, 1980, Volume: 140, Issue:12

    Topics: Abnormalities, Drug-Induced; Cleft Lip; Cleft Palate; Colitis, Ulcerative; Female; Humans; Hydroceph

1980
Folic acid antagonists during pregnancy and risk of birth defects.
    The New England journal of medicine, 2001, Mar-22, Volume: 344, Issue:12

    Topics: Abnormalities, Drug-Induced; Cleft Lip; Female; Folic Acid Antagonists; Heart Defects, Congenital; H

2001